23063-68-5

Usage

Uses

Used in Pharmaceutical Synthesis:
1-(4-bromophenyl)-2-methylpropan-2-amine is used as a key intermediate in the synthesis of various pharmaceutical drugs. Its unique chemical structure allows for the creation of a wide range of medications with different therapeutic applications.
Used in Psychoactive Research:
As a member of the phenethylamine class, 1-(4-bromophenyl)-2-methylpropan-2-amine is used in research to understand the effects of psychoactive substances on the central nervous system. This knowledge can contribute to the development of new treatments for neurological and psychiatric disorders.
Used in Regulatory Control:
Due to its potential for misuse and psychoactive properties, 1-(4-bromophenyl)-2-methylpropan-2-amine is subject to regulatory controls in many jurisdictions. It is used as a case study for understanding the need for oversight and regulation of potentially harmful chemical compounds.
Used in Forensic Chemistry:
1-(4-broMophenyl)-2-Methylpropan-2-aMine's presence in controlled substances and its psychoactive effects make it relevant in forensic chemistry. It can be used as a marker in the detection and analysis of illegal drugs and their distribution networks.
Used in Toxicology Studies:
1-(4-bromophenyl)-2-methylpropan-2-amine's psychoactive properties and potential for misuse make it a subject of interest in toxicology studies. These studies aim to understand the compound's effects on human health and develop strategies for mitigating its harmful effects.

Upstream product

• 57469-91-7 1-(4-bromophenyl)-2-methyl-propan-2-ol 
• 6186-22-7 4-bromophenyl acetone 
• 122-09-8 Phentermin 

Downstream Products

• 808768-92-5 2-[2-(4-bromo-phenyl)-1,1-dimethyl-ethyl]-isoindole-1,3-dione 
• 808768-89-0 ethyl [4-(2-amino-2-methylpropyl)phenyl]acetate 
• 808768-90-3 {4-[2-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-2-methyl-propyl]-phenyl}-acetic acid ethyl ester 
• 1357290-72-2 KMI-1723 

Relevant academic research and scientific papers

Novel synthesis method of 2-methyl-1-substituted phenyl-2-propylamine compounds

The invention discloses a novel synthesis method of 2-methyl-1-substituted phenyl-2-propylamine compounds, and belongs to the field of material synthesis. The method comprises steps as follows: substituted benzyl halide is taken as a raw material and subj

Tripeptidic BACE1 inhibitors devised by in-silico conformational structure-based design

Previously reported pentapeptidic BACE1 inhibitors, designed using a substrate-based approach, were used as lead compounds for the further design of non-peptidic BACE1 inhibitors. Although these peptidic and non-peptidic inhibitors, with a hydroxymethylcarbonyl isostere as a substrate transition-state mimic, exhibited potent BACE1 inhibitory activities, their molecular-sizes appeared a little too big (molecular weight of >600 daltons) for developing practical anti-Alzheimer's disease drugs. To develop lower weight BACE1 inhibitors, a series of tripeptidic BACE1 inhibitors were devised using a design approach based on the conformation of a virtual inhibitor bound to the BACE1 active site, also called 'in-silico conformational structure-based design'. Although these tripeptidic BACE1 inhibitors contained some natural amino acid residues, they are expected to be useful as lead compounds for developing the next generation BACE1 inhibitors, due to their low molecular size and unique structural features compared with previously reported inhibitors.

2-(6-AMINO-PYRIDIN-3-YL)-2-HYDROXYETHYLAMINE DERIVATIVES AS BETA 2-ADRENOCEPTORS AGONISTS

The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in